Company: BenVenue Medical
Based: Santa Clara, CA
Investors: Domain Associates, Technology Partners, Versant Ventures, and DeNovo Ventures
Scoop: The spinal device company gained $35.5 milllion in a Series C financing round to continue its KAST trial for the Kiva spinal system. The device is used to treat vertebral compression fractures, and the trial will test the system against balloon kyphoplasty. The company hopes to gain FDA 510(k) clearance from the study results.
"We're impressed with Benvenue Medical's growth potential in both the VCF and fusion markets and we look forward to working with the company as it evolves into a commercially-focused organization," said Roger Quy, general partner at Technology Partners, and a new member of the board of directors.